| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Molecular Neuroendocrinology, Max Planck Institute for Experimental Medicine, D-37073 Göttingen, Germany
Reprint requests to: Dr. Klaus Eckart, Department of Molecular Neuroendocrinology, Max Planck Institute for Experimental Medicine, Hermann Rein Str. 3, 37073 Göttingen, Germany; e-mail: eckart{at}em.mpg.de; fax: 49-551-3899-359.
Rat corticotropin-releasing factor receptor 1 (rCRFR1) was produced either in transfected HEK 293 cells as a complex glycosylated protein or in the presence of the mannosidase I inhibitor kifunensine as a high mannose glycosylated protein. The altered glycosylation did not influence the biological function of rCRFR1 as demonstrated by competitive binding of rat urocortin (rUcn) or human/rat corticotropin-releasing factor (h/rCRF) and agonist-induced cAMP accumulation. The low production rate of the N-terminal domain of rCRFR1 (rCRFR1-NT) by transfected HEK 293 cells, was increased by a factor of 100 in the presence of kifunensine. The product, rCRFR1-NT-Kif, bound rUcn specifically (KD = 27 nM) and astressin (KI = 60 nM). This affinity was 10-fold lower than the affinity of full length rCRFR1. However, it was sufficiently high for rCRFR1-NT-Kif to serve as a model for the N-terminal domain of rCRFR1. With protein fragmentation, Edman degradation, and mass spectrometric analysis, evidence was found for the signal peptide cleavage site C-terminally to Thr23 and three disulfide bridges between precursor residues 30 and 54, 44 and 87, and 68 and 102. Of all putative N-glycosylation sites in positions 32, 38, 45, 78, 90, and 98, all Asn residues except for Asn32 were glycosylated to a significant extent. No O-glycosylation was observed.
Keywords: Corticotropin-releasing factor; CRF receptor; human embryonic kidney cells; scintillation proximity assay; amino-terminal domain; binding domain; disulfide bond structure; glycosylation structure
Abbreviations: CRF, corticotropin-releasing factor • Ucn, urocortin • Svg, sauvagine • CRFR, CRF receptor • rCRFR, rat CRFR • hCRFR, human CRFR • mCRFR, mouse CRFR • xCRFR, Xenopus laevis CRFR • rCRFBP, rat CRF binding protein • NT, amino-terminal domain • Ast, astressin • EC, extracellular domain • HEK, human embryonic kidney • SPA, scintillation proximity assay • SDS-PAGE, SDS-polyacrylamide gel electrophoresis • EndoHf, endo-ß-acetylglucosaminidase H • PNGaseF, peptide-N-glycosidase F • WGA, wheat germ agglutinin • RP-HPLC, reversed phase-high performance liquid chromatography • NanoESMS, nano-electrospray mass spectrometry • rCRFR1-NT-Kif, rCRFR1-NT expressed in presence of kifunensine • rCRFR1-Kif, rCRFR1 expressed in presence of kifunensine • GPCR, G protein-coupled receptor
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Assil-Kishawi, T. A. Samra, D. F. Mierke, and A. B. Abou-Samra Residue 17 of Sauvagine Cross-links to the First Transmembrane Domain of Corticotropin-releasing Factor Receptor 1 (CRFR1) J. Biol. Chem., December 19, 2008; 283(51): 35644 - 35651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Mesleh, W. A. Shirley, C. E. Heise, N. Ling, R. A. Maki, and R. P. Laura NMR Structural Characterization of a Minimal Peptide Antagonist Bound to the Extracellular Domain of the Corticotropin-releasing Factor1 Receptor J. Biol. Chem., March 2, 2007; 282(9): 6338 - 6346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rutz, A. Renner, M. Alken, K. Schulz, M. Beyermann, B. Wiesner, W. Rosenthal, and R. Schulein The Corticotropin-releasing Factor Receptor Type 2a Contains an N-terminal Pseudo Signal Peptide J. Biol. Chem., August 25, 2006; 281(34): 24910 - 24921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Hillhouse and D. K. Grammatopoulos The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology Endocr. Rev., May 1, 2006; 27(3): 260 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Klose, N. Wendt, S. Kubald, E. Krause, K. Fechner, M. Beyermann, M. Bienert, R. Rudolph, and S. Rothemund Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a Protein Sci., September 1, 2004; 13(9): 2470 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. R. Grace, M. H. Perrin, M. R. DiGruccio, C. L. Miller, J. E. Rivier, W. W. Vale, and R. Riek NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor PNAS, August 31, 2004; 101(35): 12836 - 12841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tezval, O. Jahn, C. Todorovic, A. Sasse, K. Eckart, and J. Spiess Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model PNAS, June 22, 2004; 101(25): 9468 - 9473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Perrin, M. R. DiGruccio, S. C. Koerber, J. E. Rivier, K. S. Kunitake, D. L. Bain, W. H. Fischer, and W. W. Vale A Soluble Form of the First Extracellular Domain of Mouse Type 2beta Corticotropin-releasing Factor Receptor Reveals Differential Ligand Specificity J. Biol. Chem., April 25, 2003; 278(18): 15595 - 15600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lopez de Maturana, A. Willshaw, A. Kuntzsch, R. Rudolph, and D. Donnelly The Isolated N-terminal Domain of the Glucagon-like Peptide-1 (GLP-1) Receptor Binds Exendin Peptides with Much Higher Affinity than GLP-1 J. Biol. Chem., March 14, 2003; 278(12): 10195 - 10200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. J. Hoare, S. K. Sullivan, N. Ling, P. D. Crowe, and D. E. Grigoriadis Mechanism of Corticotropin-Releasing Factor Type I Receptor Regulation by Nonpeptide Antagonists Mol. Pharmacol., March 1, 2003; 63(3): 751 - 765. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
